Current status of cytotoxic chemotherapy in hormone refractory prostate cancer.

Abstract:

:Adenocarcinoma of the prostate is the most prevalent neoplastic disease in men and continues to be a major cause of morbidity and mortality. Death from prostate cancer is associated with objective and biochemical progression following hormonal manipulations often described as hormone refractory prostate cancer (HRPCA). Therapy for HRPCA is primarily palliative and therapeutic efficacy has to be balanced against potential treatment-related side effects. Therapeutic efficacy may be assessed by evaluating the percentage of patients obtaining a PSA decline of > 50%, evaluating the response of bidimensionally measurable disease or by improvements in quality of life assessments. The most effective cytotoxic therapies at the present time seem to be combinations of estramustine phosphate with taxanes and etoposide. Regimes employing ketoconazole with estramustine, vinblastine or bisphosphonates seem to be worthy of further evaluation. Mitoxantrone has an impressive palliative effect in patients, particularly when combined with hydrocortisone. Oral chemotherapeutic regimens with a combination of estramustine phosphate, cyclophosphamide and prednisone appear to offer a less toxic alternative. For the future we need prospective randomized clinical phase-III studies, prognosticators identifying patients as being at high or low risk who might benefit from different therapeutic approaches and generally binding eligibility and response guidelines in order to be able to compare trials of different therapeutic approaches.

journal_name

Eur Urol

journal_title

European urology

authors

Heidenreich A,von Knobloch R,Hofmann R

doi

10.1159/000052426

keywords:

subject

Has Abstract

pub_date

2001-02-01 00:00:00

pages

121-30

issue

2

eissn

0302-2838

issn

1873-7560

pii

52426

journal_volume

39

pub_type

杂志文章,评审
  • In vitro tumoral progression of human bladder carcinoma: role for TGFbeta.

    abstract:OBJECTIVE:Investigating whether extracellular factors are possible actors in tumoral progression in bladder carcinoma. METHODS:RT112/G2 bladder tumour cells were grown in presence of TGFbeta and analysed by immunological and cDNA microarray techniques. RESULTS:TGFbeta inhibited cell proliferation, reduced TNFalpha- a...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1016/j.eururo.2005.06.005

    authors: Champelovier P,El Atifi M,Mantel F,Rostaing B,Simon A,Berger F,Seigneurin D

    更新日期:2005-11-01 00:00:00

  • Genetic influence on stress urinary incontinence and pelvic organ prolapse.

    abstract:OBJECTIVES:To determine the genetic and environmental influence on the liability for stress urinary incontinence and pelvic organ prolapse surgery. METHODS:We used the Swedish Twin Registry to identify all same-sex female twin pairs with known zygosity born from 1926 to 1958. Occurrence of stress urinary incontinence ...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1016/j.eururo.2007.12.004

    authors: Altman D,Forsman M,Falconer C,Lichtenstein P

    更新日期:2008-10-01 00:00:00

  • The effect of tumor location on prognosis in patients treated with radical nephroureterectomy at Memorial Sloan-Kettering Cancer Center.

    abstract:BACKGROUND:The prognostic impact of primary tumor location on outcomes for patients with upper-tract urothelial carcinoma (UTUC) is still contentious. OBJECTIVE:To test the association between tumor location and disease recurrence and cancer-specific survival (CSS) in patients treated with radical nephroureterectomy (...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1016/j.eururo.2010.07.003

    authors: Favaretto RL,Shariat SF,Chade DC,Godoy G,Adamy A,Kaag M,Bochner BH,Coleman J,Dalbagni G

    更新日期:2010-10-01 00:00:00

  • Place of double-J stents in extracorporeal shock wave lithotripsy.

    abstract::Although double-J stents (DJS) are used to reduce complications following extracorporeal shock wave lithotripsy (ESWL), there has recently been a tendency to limit their use because of complications. We retrospectively reviewed 351 patients with renal stones larger than 30 mm to determine the effectiveness and the com...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1159/000474653

    authors: Kirkali Z,Esen AA,Akan G

    更新日期:1993-01-01 00:00:00

  • Continent ileal pouch using the serous-lined principle.

    abstract:OBJECTIVES:The flap valve principle is not easily applicable to an ileal pouch since a submucosal tunnel is difficult to create. We attempted to construct an ileal pouch with an umbilical stoma applying the serous-lined principle for both ureteral implantation and construction of a continent valve. METHODS:In 9 patien...

    journal_title:European urology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000020260

    authors: Kato H,Igawa Y,Kiyokawa H,Iwata K,Nishizawa O

    更新日期:2000-07-01 00:00:00

  • Pathologic Outcomes in Favorable-risk Prostate Cancer: Comparative Analysis of Men Electing Active Surveillance and Immediate Surgery.

    abstract:BACKGROUND:It remains unclear whether men selecting active surveillance (AS) are at increased risk of unfavorable longer term outcomes as compared with men who undergo immediate treatment. OBJECTIVE:To compare adverse pathologic outcomes in men with favorable-risk prostate cancer who underwent delayed prostatectomy af...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1016/j.eururo.2015.09.032

    authors: Tosoian JJ,Sundi D,Trock BJ,Landis P,Epstein JI,Schaeffer EM,Carter HB,Mamawala M

    更新日期:2016-04-01 00:00:00

  • Accuracy of frozen section examination of testicular tumors of uncertain origin.

    abstract:INTRODUCTION:A total of 80-90% of all testicular masses are malignant germ cell tumors. Benign testicular lesions are recognized in approximately 10-20% enabling a testis-preserving surgery on the findings of frozen section examination (FSE). However, there are only sparse information with regard to the reliability of ...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1016/s0302-2838(02)00004-0

    authors: Elert A,Olbert P,Hegele A,Barth P,Hofmann R,Heidenreich A

    更新日期:2002-03-01 00:00:00

  • Best practices in robot-assisted radical cystectomy and urinary reconstruction: recommendations of the Pasadena Consensus Panel.

    abstract:CONTEXT:Robot-assisted surgery is increasingly used for radical cystectomy (RC) and urinary reconstruction. Sufficient data have accumulated to allow evidence-based consensus on key issues such as perioperative management, comparative effectiveness on surgical complications, and oncologic short- to midterm outcomes. O...

    journal_title:European urology

    pub_type: 共识发展会议,杂志文章,实务指引,评审

    doi:10.1016/j.eururo.2014.12.009

    authors: Wilson TG,Guru K,Rosen RC,Wiklund P,Annerstedt M,Bochner BH,Chan KG,Montorsi F,Mottrie A,Murphy D,Novara G,Peabody JO,Palou Redorta J,Skinner EC,Thalmann G,Stenzl A,Yuh B,Catto J,Pasadena Consensus Panel.

    更新日期:2015-03-01 00:00:00

  • Intratumoral Heterogeneity of Bladder Cancer by Molecular Subtypes and Histologic Variants.

    abstract::Molecular subtyping may inform on prognosis and treatment response in bladder cancer. However, intratumoral molecular heterogeneity is not well studied in this disease and could complicate efforts to use molecular subtyping to guide patient management. To investigate intratumoral heterogeneity in bladder cancer, we ex...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1016/j.eururo.2018.09.003

    authors: Warrick JI,Sjödahl G,Kaag M,Raman JD,Merrill S,Shuman L,Chen G,Walter V,DeGraff DJ

    更新日期:2019-01-01 00:00:00

  • Does primary androgen-deprivation therapy delay the receipt of secondary cancer therapy for localized prostate cancer?

    abstract:BACKGROUND:Despite evidence that shows no survival advantage, many older patients receive primary androgen-deprivation therapy (PADT) shortly after the diagnosis of localized prostate cancer (PCa). OBJECTIVE:This study evaluates whether the early use of PADT affects the subsequent receipt of additional palliative canc...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1016/j.eururo.2012.05.003

    authors: Lu-Yao GL,Albertsen PC,Li H,Moore DF,Shih W,Lin Y,DiPaola RS,Yao SL

    更新日期:2012-12-01 00:00:00

  • Bladder neck wrap: a modified fascial sling in treatment of incontinence in myelomeningocele patients.

    abstract::In a large percentage of myelomeningocele patients the bladder neck and posterior urethra are widely open. Pubovaginal or puboprostatic sling has been proposed to achieve continence. Herein, a further modification of the fascial sling is presented. By wrapping the sling around the bladder neck more coaptation is achie...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1159/000475315

    authors: Ghoniem GM

    更新日期:1994-01-01 00:00:00

  • Influence of the severity of stress urinary incontinence on quality of life, health care seeking, and treatment: A national cross-sectional survey.

    abstract:OBJECTIVES:To determine the prevalence of stress urinary incontinence (SUI) symptoms in women and to evaluate the severity of these symptoms and resulting functional impairment with regard to urinary symptoms, quality of life (QoL) impairment, medical care seeking, and care facilities. METHODS:A national population ba...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1016/j.eururo.2006.03.052

    authors: Gasquet I,Tcherny-Lessenot S,Gaudebout P,Bosio Le Goux B,Klein P,Haab F

    更新日期:2006-10-01 00:00:00

  • Efficacy, safety, and tolerability of mirabegron in patients aged ≥65yr with overactive bladder wet: a phase IV, double-blind, randomised, placebo-controlled study (PILLAR).

    abstract:BACKGROUND:The majority of patients with overactive bladder (OAB) are aged >65yr. There has been no prospectively designed study assessing treatment efficacy with the β3-adrenoreceptor agonist, mirabegron, specifically in this age group. OBJECTIVE:A phase IV study comparing flexibly dosed mirabegron versus placebo in ...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1016/j.eururo.2019.10.002

    authors: Wagg A,Staskin D,Engel E,Herschorn S,Kristy RM,Schermer CR

    更新日期:2020-02-01 00:00:00

  • Is benign prostatic hyperplasia (BPH) an immune inflammatory disease?

    abstract:OBJECTIVES:Chronic inflammation has been documented for years in benign prostatic hyperplasia (BPH), but only now has it become evident as a major factor in disease progression. This review highlights the immunologic key features of chronic inflammation in BPH and the present interpretation of these changes in the deve...

    journal_title:European urology

    pub_type: 杂志文章,评审

    doi:10.1016/j.eururo.2006.12.011

    authors: Kramer G,Mitteregger D,Marberger M

    更新日期:2007-05-01 00:00:00

  • Importance of individual response in symptom score evaluation.

    abstract::In making treatment decisions for patients with benign prostatic hyperplasia (BPH), physicians have to rely on the efficacy data published in the literature and adapt this to individual patient's needs. Criticism can be made, however, of the randomised clinical trials (RCTs) that are performed, as the patients enrolle...

    journal_title:European urology

    pub_type: 杂志文章,评审

    doi:10.1159/000049884

    authors: Desgrandchamps F

    更新日期:2001-01-01 00:00:00

  • A proposal for reclassification of the Fuhrman grading system in patients with clear cell renal cell carcinoma.

    abstract:BACKGROUND:The conventional Fuhrman grading system, which categorizes renal cell carcinoma (RCC) with grades I, II, III, and IV, is the most widely used predictor assessment of RCC cancer-specific mortality (CSM). OBJECTIVES:The aim of this study was to test the prognostic ability of simplified Fuhrman grading schemes...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1016/j.eururo.2009.06.008

    authors: Sun M,Lughezzani G,Jeldres C,Isbarn H,Shariat SF,Arjane P,Widmer H,Pharand D,Latour M,Perrotte P,Patard JJ,Karakiewicz PI

    更新日期:2009-11-01 00:00:00

  • Moving beyond the headlines: improving the technical quality of radical prostatectomy.

    abstract::Recent work from surgeons in Europe and the United States has provided both the motivation, and a blueprint, for implementing peer assessments of technical skill as a robust and practical strategy for evaluating and ultimately improving technical expertise with radical prostatectomy. ...

    journal_title:European urology

    pub_type: 评论,社论

    doi:10.1016/j.eururo.2014.02.009

    authors: Miller DC,Birkmeyer JD

    更新日期:2014-06-01 00:00:00

  • Robotic Partial Nephrectomy: The Will Rogers Surgical Effect.

    abstract::Comparison of surgical techniques must be critically and objectively evaluated, ideally in the context of prospective trials. Comprehensive surgical training ensures that patients are offered the most appropriate treatment and highest clinical care. ...

    journal_title:European urology

    pub_type: 评论,社论

    doi:10.1016/j.eururo.2015.07.033

    authors: George AK,Hartman C,Kavoussi LR

    更新日期:2016-01-01 00:00:00

  • Neuroendocrine differentiation in hormone refractory prostate cancer following androgen deprivation therapy.

    abstract:OBJECTIVE:To evaluate the relationship between neuroendocrine differentiation (NED) status and hormone refractory prostate cancer (HRPC) following hormone therapy based on immunohistochemical study. METHODS:Seventy-two prostate cancer specimens obtained at radical prostatectomy and 21 prostate cancer autopsy specimens...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1016/j.eururo.2003.11.032

    authors: Hirano D,Okada Y,Minei S,Takimoto Y,Nemoto N

    更新日期:2004-05-01 00:00:00

  • Topography of lymph node metastases in prostate cancer patients undergoing radical prostatectomy and extended lymphadenectomy: results of a combined molecular and histopathologic mapping study.

    abstract:BACKGROUND:To determine the anatomic extent of pelvic lymph node dissection (PLND) in prostate cancer (PCa) patients at the time of radical prostatectomy (RP), knowledge about the topography of lymph node (LN) metastases is required. OBJECTIVE:Because small-volume LN metastases may be missed by standard histopathologi...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1016/j.eururo.2013.02.007

    authors: Heck MM,Retz M,Bandur M,Souchay M,Vitzthum E,Weirich G,Mollenhauer M,Schuster T,Autenrieth M,Kübler H,Maurer T,Thalgott M,Herkommer K,Gschwend JE,Nawroth R

    更新日期:2014-08-01 00:00:00

  • Complications of laparoscopic and percutaneous renal cryoablation in a single tertiary referral center.

    abstract:BACKGROUND:Laparoscopic cryoablation (LCA) and percutaneous cryoablation (PCA) of small renal masses have gained popularity, but only limited data exist on the complication rates. OBJECTIVES:In this study, we report on postoperative complications associated with LCA and PCA in a single tertiary center experience. DES...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1016/j.eururo.2010.03.035

    authors: Tsivian M,Chen VH,Kim CY,Zilberman DE,Mouraviev V,Nelson RC,Albala DM,Polascik TJ

    更新日期:2010-07-01 00:00:00

  • Telesurgical laparoscopic radical prostatectomy. Initial experience.

    abstract:INTRODUCTION:Telepresence surgery offers theoretically to overcome two main problems of laparoscopic surgery, i.e. the limitation to only four degrees of freedom and the lack of stereovision. Since 1998, telesurgical minimally invasive procedures have been performed with the da Vinci system mainly for cardiac bypass su...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1159/000049752

    authors: Rassweiler J,Frede T,Seemann O,Stock C,Sentker L

    更新日期:2001-07-01 00:00:00

  • Use of computerized cell image analysis to characterize cell nucleus populations from normal and neoplastic renal tissues.

    abstract::We studied 55 renal tissue samples from 16 patients corresponding to normal (19 samples, group 1), low-grade (18 samples, group 2), and high-grade (18 samples, group 3) tumoral tissues. For this purpose, we used digital cell image analysis (the SAMBA 200 processor) to describe the morphonuclear patterns of Feulgen-sta...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1159/000473605

    authors: vanden Houte K,Kiss R,de Prez C,Verhest A,Pasteels JL,van Velthoven R

    更新日期:1991-01-01 00:00:00

  • Prognostic value of the serum levels of bone formation and bone resorption markers in prostate cancer patients with bone metastasis.

    abstract:OBJECTIVE:The aim of the present study was to determine whether the serum levels of a bone formation marker, i.e., the carboxy-terminal propeptide of type I procollagen (PICP), and a bone resorption marker, i.e., the carboxy-terminal telopeptide of type I collagen (ICTP) have prognostic value in prostate cancer patient...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1159/000019700

    authors: Akimoto S,Inomiya H,Furuya Y,Akakura K,Ito H

    更新日期:1998-08-01 00:00:00

  • Significant antitumor effect of intratumoral ethanol injection on renal cell carcinoma.

    abstract:OBJECTIVE:The effects of intratumoral ethanol injection on renal cell carcinoma (RCC) heterotransplanted in nude rats were evaluated. MATERIALS AND METHODS:The OUR95AF human RCC cell line was inoculated subcutaneously into the backs of nude rats. Four weeks after transplantation, the size of tumors became 1.5-2.0 cm i...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1016/s0302-2838(03)00354-3

    authors: Naitoh Y,Kawauchi A,Mizutani Y,Ukimura O,Fujito A,Nakao M,Kojima Y,Nonomura N,Okuyama A,Miki T

    更新日期:2003-10-01 00:00:00

  • A case of nonseminomatous testicular tumor with liver metastases, treated by intrahepatic arterial cisplatinum-diaminedichloride infusion.

    abstract::We report a case of nonseminomatous testicular tumor with lymph node involvement and multiple lung and liver metastases. The patient was considered to have a poor prognosis. He received systemic chemotherapy and cytoreductive surgery. Postoperatively a residual metastatic tumor in the liver was treated by intrahepatic...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1159/000463917

    authors: Kawai K,Sasaki A,Nishijima Y,Kikuchi K,Ohtani M,Rinshou K,Koiso K,Adachi S,Ishikawa A,Iwasaki Y

    更新日期:1990-01-01 00:00:00

  • Phosphodiesterase type 5 inhibitors: the day after.

    abstract:OBJECTIVE:Review the literature on phosphodiesterase type 5 inhibitors (PDE5-Is), addressing critical issues in their current and future use, assessing unanswered questions, and identifying research needs. METHODS:A MEDLINE search was conducted on PDE5-Is, with emphasis on clinical trials and experience, for interpret...

    journal_title:European urology

    pub_type: 杂志文章,评审

    doi:10.1016/j.eururo.2006.07.020

    authors: Hatzimouratidis K,Hatzichristou D

    更新日期:2007-01-01 00:00:00

  • Exploring Variation in the Use of Conservative Management for Low-risk Prostate Cancer in the Veterans Affairs Healthcare System.

    abstract::Current guidelines recommend conservative management as the preferred option for most low-risk prostate cancer cases, with certain possible exceptions (age <55yr, African Americans, and high-volume grade group 1). Although previous studies have documented substantial heterogeneity in the uptake of conservative managem...

    journal_title:European urology

    pub_type: 杂志文章,评审

    doi:10.1016/j.eururo.2020.02.004

    authors: Loeb S,Byrne NK,Wang B,Makarov DV,Becker D,Wise DR,Lepor H,Walter D

    更新日期:2020-06-01 00:00:00

  • The impact of androgen deprivation therapy on health related quality of life in asymptomatic men with lymph node positive prostate cancer.

    abstract:PURPOSE:To evaluate the impact of androgen deprivation on health related quality of life (HRQOL) in patients with asymptomatic lymph node positive prostatic carcinoma (LPPC). MATERIALS AND METHODS:HRQOL domains were measured, using standard instruments in 91 patients with histologically proven LPPC. Most patients were...

    journal_title:European urology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/s0302-2838(03)00208-2

    authors: van Andel G,Kurth KH

    更新日期:2003-08-01 00:00:00

  • Genomic Characterization of Renal Cell Carcinoma with Sarcomatoid Dedifferentiation Pinpoints Recurrent Genomic Alterations.

    abstract:BACKGROUND:The genomic features underpinning renal cell carcinoma with sarcomatoid dedifferentiation (sRCC) are not well understood, and at present, there are no specific or effective therapies for sRCC. OBJECTIVE:To identify genomic alterations in patients with sRCC. DESIGN, SETTING, AND PARTICIPANTS:We conducted ge...

    journal_title:European urology

    pub_type: 杂志文章

    doi:10.1016/j.eururo.2016.01.051

    authors: Malouf GG,Ali SM,Wang K,Balasubramanian S,Ross JS,Miller VA,Stephens PJ,Khayat D,Pal SK,Su X,Sircar K,Tamboli P,Jonasch E,Tannir NM,Wood CG,Karam JA

    更新日期:2016-08-01 00:00:00